Pancreatic Cancer Clinical Trials

Showing 461-480 of 1,185 trials

Gastrointestinal Microflora and Serum Metabolomics in Patients With Pancreatic Cancer and Chronic Pancreatitis

NCT06411470

The investigators plan to collect throat swabs, saliva, feces and serum samples from pancreatic cancer patients, chronic pancreatitis patients and healthy people and clarify the characteristics of oral flora and serum metabolome of pancreatic cancer patients.

Pancreatic CancerChronic Pancreatitis

Changhai Hospital600 participantsStarted Apr 2024

Shanghai, Shanghai Municipality, China

Not Yet RecruitingPhase 2

A Phase II Study of Surufatinib Combined With Camrelizumab and mFOLFOX6 as Second-line Treatment for Advanced PRAD

NCT06329947

To preliminarily evaluate whether there is a survival benefit of surufatinib combined with camrelizumab and mFOLFOX6 as the second-line treatment for advanced pancreatic cancer, and to explore the feasibility of second-line and post-line treatment for advanced pancreatic cancer

Advanced Pancreatic Cancer

Rui-hua Xu, MD, PhD37 participantsStarted May 2024

Guangzhou, China

RECRUITINGPhase 4

The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer

NCT06368063

The study is a multicenter, prospective clinical study aimed at evaluating the efficacy and safety of Huaier Granule in postoperative adjuvant treatment of resectable pancreatic cancer

Pancreatic Cancer Resectable

Xi'an Jiaotong University642 participantsStarted May 2024

Xi'an, Shannxi, China

Gastrointestinal Microflora and Serum Metabolomics in Patients With Pancreatic Cancer and Chronic Pancreatitis

A Phase II Study of Surufatinib Combined With Camrelizumab and mFOLFOX6 as Second-line Treatment for Advanced PRAD

The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer

Related Searches

IORT on Borderline Resectable Pancreatic Cancer

Olaparib in PALB2 Advanced Pancreatic Cancer

Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer

Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours

Pancreatic Cancer Initial Detection Via Liquid Biopsy

Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients

The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma

Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer

Evaluation of Endoscopic Ultrasound Shear Wave Elastography (EUS-SWE) for the Diagnosis of Pancreatic Adenocarcinoma.

LAMS Choledochoduodenostomies: With or Without Coaxial Plastic Stent

Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer

Quebec Pancreas Cancer Study

Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis

Liver Embolization Approaches for Tumor Management

Radiology Registry on Pancreatic Malignancies

Registry for Advanced Endoscopy

Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer